Bayer's CEO to step down by 2016

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2014

Singapore: German drugmaker Bayer announced that Dr Marjin Dekkers will step down as the CEO, by the end of 2016. The fi...Read more

Lupin gets FDA approval for Lyrica generic

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 06 Jul, 2012

Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...Read more

Indian state to slash prices of 348 drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...Read more

Daiichi to work with US FDA to solve Ranbaxy quality issue

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2013

Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the...Read more

Ranbaxy aiming to sell its generics in Japan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2013

Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...Read more

Ranbaxy claims FDA form '483' not a show stopper

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

Singapore: Soon after reports of Ranbaxy's Mohali manufacturing plant being issued a Form 483 by the US US FDA broke out...Read more

Astellas joins hands with Tecnofarma International

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2013

Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...Read more

Generic sodium tablets from Dr. Reddy's, Mylan hit US market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

Mumbai: Dr. Reddy's Laboratories, India's leading pharmaceutical company, recently launched Montelukast Sodium Tablets a...Read more

Generics take center stage in South East Asia

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 21 Aug, 2013

Singapore: The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The in...Read more

China: GSK used sexual bribery to boost sales

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been de...Read more

Mayne Pharma acquires generic drugmaker Libertas

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugma...Read more

Bribery inquiries rising in China: SPP

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or in...Read more

China bans GSK finance head from leaving country

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctor...Read more

UCB sues 15 firms for patent infringement

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...Read more

Deregulation will boost Japanese pharma sector

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent o...Read more

50% of all drug firms have counter-generics team

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

Singapore: A report by Cutting Edge Information titled, 'Post-patent generic and biosimilar defense: Harnessing competit...Read more

Diabetes drug Actos banned in India

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...Read more

Reports: GSK staff detained in 'fraud data' case in China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

Singapore: The Chinese police have reportedly detained employees of British pharmaceuticals major GlaxoSmithKline (GSK) ...Read more